Log In
Print
BCIQ
Print
Print this Print this
 

FluMist Quadrivalent (MEDI-3250)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionLive, attenuated intranasal influenza virus vaccine (quadrivalent)
Molecular Target
Mechanism of ActionVaccine
Latest Stage of DevelopmentApproved
IndicationInfluenza virus
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today